Campbell & Co Investment Adviser Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synchrony
SYF
|
+$9.84M |
| 2 |
Labcorp
LH
|
+$8.89M |
| 3 |
Hubbell
HUBB
|
+$7.76M |
| 4 |
Sanofi
SNY
|
+$7.7M |
| 5 |
JHG
Janus Henderson
JHG
|
+$7.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intercontinental Exchange
ICE
|
+$10.4M |
| 2 |
Fastenal
FAST
|
+$10.2M |
| 3 |
HCA Healthcare
HCA
|
+$9.44M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$9.09M |
| 5 |
Novartis
NVS
|
+$9.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17% |
| 2 | Healthcare | 16.16% |
| 3 | Consumer Discretionary | 11.61% |
| 4 | Industrials | 11.18% |
| 5 | Technology | 9.93% |
Similar funds
Campbell & Co Investment Adviser's Q1 2025 Portfolio in Review
As of Q1 2025, Campbell & Co Investment Adviser held 1,409 positions worth $1.3B, up 0.6% from $1.3B the previous quarter. Its ten largest holdings account for 6% of the portfolio.
Campbell & Co Investment Adviser deployed $92.4M of net new capital in Q1 2025, opening 392 new positions and adding to 321 existing holdings. Its largest new stake was Synchrony: 159,080 shares worth $8.42M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Novartis, an estimated $9.01M trimmed.
- Campbell & Co Investment Adviser's largest Q1 2025 buy was Synchrony: 159,080 shares worth $8.42M.
- Campbell & Co Investment Adviser added most to Labcorp in Q1 2025, an estimated $8.89M increase.
- Campbell & Co Investment Adviser's biggest Q1 2025 reduction was Novartis, cutting an estimated $9.01M.
- Campbell & Co Investment Adviser fully exited Intercontinental Exchange in Q1 2025, selling an estimated $10.4M.
- Campbell & Co Investment Adviser's ten largest holdings make up 6% of its $1.3B portfolio in Q1 2025.
- Campbell & Co Investment Adviser opened 392 new positions and closed 417 in Q1 2025.
- Campbell & Co Investment Adviser's portfolio value rose 0.6% quarter-over-quarter to $1.3B.
Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.